$ANPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANGIOTECH PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANGIOTECH PHARMACEUTICALS INC. Get notifications about new insider transactions in ANGIOTECH PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2012 | ANPI | ANGIOTECH PHARMACE ... | Highland Crusader Offshore Par ... | 10% Owner | Sell | S | 15.43 | 1,115,000 | 17,204,450 | 432,750 | 1.5 M to 432.8 K (-72.04 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Option Exercise | J | 1.09 | 300,000 | 327,000 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Option Exercise | J | 0.38 | 500,000 | 190,000 | 300,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Option Exercise | J | 0.21 | 500,000 | 105,000 | 800,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Option Exercise | J | 8.90 | 350,000 | 3,115,000 | 1,300,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Option Exercise | J | 13.47 | 400,000 | 5,387,200 | 1,650,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 1.39 | 15,600 | 21,684 | 0 | 15.6 K to 0 (-100.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 1.90 | 47,000 | 89,300 | 15,600 | 62.6 K to 15.6 K (-75.08 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.55 | 157,738 | 86,756 | 62,600 | 220.3 K to 62.6 K (-71.59 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.54 | 476,813 | 257,479 | 220,338 | 697.2 K to 220.3 K (-68.39 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.42 | 30,500 | 12,810 | 697,151 | 727.7 K to 697.2 K (-4.19 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.31 | 53,000 | 16,430 | 727,651 | 780.7 K to 727.7 K (-6.79 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.32 | 40,848 | 13,071 | 780,651 | 821.5 K to 780.7 K (-4.97 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.31 | 89,692 | 27,805 | 821,499 | 911.2 K to 821.5 K (-9.84 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.20 | 33,000 | 6,600 | 911,191 | 944.2 K to 911.2 K (-3.50 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.16 | 156,933 | 25,109 | 944,191 | 1.1 M to 944.2 K (-14.25 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.15 | 567,595 | 85,139 | 1,101,124 | 1.7 M to 1.1 M (-34.01 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.17 | 3,332,616 | 566,545 | 1,668,719 | 5 M to 1.7 M (-66.63 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.17 | 102,000 | 17,340 | 5,001,335 | 5.1 M to 5 M (-2.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.17 | 375,000 | 63,750 | 5,103,335 | 5.5 M to 5.1 M (-6.85 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | CEO & President | Sell | J | 0.17 | 435,356 | 74,011 | 5,478,335 | 5.9 M to 5.5 M (-7.36 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Option Exercise | J | 8.90 | 65,000 | 578,500 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Option Exercise | J | 0.21 | 70,000 | 14,700 | 115,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Option Exercise | J | 0.38 | 75,000 | 28,500 | 185,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Option Exercise | J | 1.09 | 35,000 | 38,150 | 260,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Sell | J | 1.94 | 2,700 | 5,238 | 0 | 2.7 K to 0 (-100.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Sell | J | 1.95 | 8,000 | 15,600 | 2,700 | 10.7 K to 2.7 K (-74.77 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Sell | J | 1.94 | 6,000 | 11,640 | 10,700 | 16.7 K to 10.7 K (-35.93 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Cunliffe Sean | SVP, Sales & Market ... | Option Exercise | J | 1.28 | 100,000 | 128,000 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Cunliffe Sean | SVP, Sales & Market ... | Option Exercise | J | 1.05 | 85,000 | 89,250 | 100,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Cunliffe Sean | SVP, Sales & Market ... | Sell | J | 0.00 | 70,700 | 0 | 70,700 | 141.4 K to 70.7 K (-50.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | J | 1.05 | 50,000 | 52,500 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | J | 0.27 | 22,000 | 5,940 | 50,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | J | 0.26 | 25,000 | 6,500 | 72,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | J | 7.65 | 15,000 | 114,750 | 97,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | J | 15.44 | 19,261 | 297,390 | 112,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | J | 15.44 | 19,261 | 297,390 | 131,261 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Option Exercise | J | 7.65 | 175,000 | 1,338,750 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Option Exercise | J | 13.47 | 50,000 | 673,400 | 175,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Option Exercise | J | 0.16 | 200,000 | 32,000 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Option Exercise | J | 0.16 | 200,000 | 32,000 | 200,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Option Exercise | J | 0.27 | 200,000 | 54,000 | 400,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Option Exercise | J | 1.05 | 135,000 | 141,750 | 600,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Sell | J | 0.00 | 800 | 0 | 0 | 800 to 0 (-100.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal | Sell | J | 0.00 | 2,000 | 0 | 800 | 2.8 K to 800 (-71.43 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | J | 8.90 | 50,000 | 445,000 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | J | 0.21 | 150,000 | 31,500 | 50,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | J | 0.38 | 150,000 | 57,000 | 200,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | J | 1.09 | 85,000 | 92,650 | 350,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Sell | J | 1.35 | 5,500 | 7,425 | 0 | 5.5 K to 0 (-100.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Sell | J | 1.90 | 3,300 | 6,270 | 5,500 | 8.8 K to 5.5 K (-37.50 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Sell | J | 1.91 | 3,000 | 5,730 | 8,800 | 11.8 K to 8.8 K (-25.42 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 7.61 | 25,000 | 190,250 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 0.21 | 100,000 | 21,000 | 25,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 0.38 | 150,000 | 57,000 | 125,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 1.09 | 85,000 | 92,650 | 275,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.85 | 12,500 | 23,125 | 0 | 12.5 K to 0 (-100.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.77 | 20,000 | 35,400 | 12,500 | 32.5 K to 12.5 K (-61.54 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.80 | 2,000 | 3,600 | 32,500 | 34.5 K to 32.5 K (-5.80 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.72 | 1,500 | 2,580 | 34,500 | 36 K to 34.5 K (-4.17 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.68 | 6,000 | 10,080 | 36,000 | 42 K to 36 K (-14.29 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.11 | 9,000 | 9,990 | 42,000 | 51 K to 42 K (-17.65 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | J | 7.65 | 200,000 | 1,530,000 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | J | 0.16 | 250,000 | 40,000 | 200,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | J | 0.27 | 250,000 | 67,500 | 450,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | J | 1.05 | 160,000 | 168,000 | 700,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Sell | J | 1.70 | 13,900 | 23,630 | 0 | 13.9 K to 0 (-100.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Sell | J | 1.69 | 1,100 | 1,859 | 13,900 | 15 K to 13.9 K (-7.33 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Sell | J | 1.64 | 15,000 | 24,600 | 15,000 | 30 K to 15 K (-50.00 %) |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Diaz Victor Manuel | SVP, Global Manufac ... | Option Exercise | J | 5.69 | 30,000 | 170,700 | 0 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Diaz Victor Manuel | SVP, Global Manufac ... | Option Exercise | J | 0.16 | 150,000 | 24,000 | 30,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Diaz Victor Manuel | SVP, Global Manufac ... | Option Exercise | J | 0.27 | 150,000 | 40,500 | 180,000 | |
May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Diaz Victor Manuel | SVP, Global Manufac ... | Option Exercise | J | 1.05 | 85,000 | 89,250 | 330,000 | |
Mar 26 2010 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.11 | 9,000 | 9,990 | 51,000 | 42 K to 51 K (+21.43 %) |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Bryant Steven R. | SVP, Specialty Medi ... | Option Exercise | A | 1.05 | 50,000 | 52,500 | 112,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Option Exercise | A | 1.09 | 35,000 | 38,150 | 295,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Cunliffe Sean | SVP, Sales & Market ... | Option Exercise | A | 1.05 | 85,000 | 89,250 | 185,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Diaz Victor Manuel | SVP, Global Manufac ... | Option Exercise | A | 1.05 | 85,000 | 89,250 | 415,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal & Genera ... | Option Exercise | A | 1.05 | 135,000 | 141,750 | 760,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | A | 1.05 | 160,000 | 168,000 | 800,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | A | 1.09 | 85,000 | 92,650 | 435,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Chen Jonathan W | SVP, Business Devel ... | Option Exercise | A | 1.09 | 85,000 | 92,650 | 510,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | A | 1.09 | 85,000 | 92,650 | 360,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | A | 1.09 | 135,000 | 147,150 | 790,000 | |
Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President and CEO | Option Exercise | A | 1.09 | 300,000 | 327,000 | 2,050,000 | |
Dec 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Willms Arthur H | Director | Option Exercise | A | 1.41 | 12,500 | 17,625 | 62,500 | |
Dec 14 2009 | ANPI | ANGIOTECH PHARMACE ... | HOWARD DAVID T | Director | Option Exercise | A | 1.41 | 12,500 | 17,625 | 167,500 | |
Dec 14 2009 | ANPI | ANGIOTECH PHARMACE ... | MCKINNELL HENRY A | Director | Option Exercise | A | 1.35 | 12,500 | 16,875 | 62,500 | |
Dec 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Brown Edward M | Director | Option Exercise | A | 1.35 | 12,500 | 16,875 | 57,500 | |
Dec 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Brege Laura | Director | Option Exercise | A | 1.35 | 12,500 | 16,875 | 42,500 | |
Nov 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Buy | P | 1.40 | 11,100 | 15,540 | 5,913,691 | 5.9 M to 5.9 M (+0.19 %) |
Nov 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Buy | P | 1.39 | 1,500 | 2,085 | 5,902,591 | 5.9 M to 5.9 M (+0.03 %) |
Nov 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Buy | P | 1.38 | 3,000 | 4,140 | 5,901,091 | 5.9 M to 5.9 M (+0.05 %) |
Nov 12 2009 | ANPI | ANGIOTECH PHARMACE ... | Cunliffe Sean | SVP, Sales & Market ... | Option Exercise | A | 1.28 | 100,000 | 128,000 | 100,000 | |
Sep 30 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President and CEO | Buy | P | 1.90 | 2,200 | 4,180 | 5,898,091 | 5.9 M to 5.9 M (+0.04 %) |
Sep 30 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President and CEO | Buy | P | 1.89 | 300 | 567 | 5,895,891 | 5.9 M to 5.9 M (+0.01 %) |
Sep 30 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President and CEO | Buy | P | 1.91 | 20,000 | 38,200 | 5,895,591 | 5.9 M to 5.9 M (+0.34 %) |
Sep 30 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President and CEO | Buy | P | 1.90 | 21,600 | 41,040 | 5,875,591 | 5.9 M to 5.9 M (+0.37 %) |
Sep 30 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President and CEO | Buy | P | 1.89 | 5,400 | 10,206 | 5,853,991 | 5.8 M to 5.9 M (+0.09 %) |
Aug 31 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.68 | 6,000 | 10,080 | 36,600 | 30.6 K to 36.6 K (+19.61 %) |
Aug 19 2009 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Buy | P | 1.70 | 13,900 | 23,630 | 30,000 | 16.1 K to 30 K (+86.34 %) |
Aug 19 2009 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Buy | P | 1.69 | 1,100 | 1,859 | 16,100 | 15 K to 16.1 K (+7.33 %) |
Aug 19 2009 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Buy | P | 1.64 | 15,000 | 24,600 | 15,000 | 0 to 15 K |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Buy | P | 1.91 | 3,000 | 5,730 | 11,800 | 8.8 K to 11.8 K (+34.09 %) |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Buy | P | 1.90 | 3,300 | 6,270 | 8,800 | 5.5 K to 8.8 K (+60.00 %) |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.72 | 1,500 | 2,580 | 36,000 | 34.5 K to 36 K (+4.35 %) |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.80 | 2,000 | 3,600 | 34,500 | 32.5 K to 34.5 K (+6.15 %) |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Buy | P | 1.96 | 6,000 | 11,760 | 16,700 | 10.7 K to 16.7 K (+56.07 %) |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Buy | P | 1.95 | 8,000 | 15,600 | 10,700 | 2.7 K to 10.7 K (+296.30 %) |
Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Dent Jay Bernard | SVP, Finance | Buy | P | 1.94 | 2,700 | 5,238 | 2,700 | 0 to 2.7 K |
Aug 13 2009 | ANPI | ANGIOTECH PHARMACE ... | Willms Arthur H | Director | Buy | P | 1.92 | 25,000 | 48,000 | 80,760 | 55.8 K to 80.8 K (+44.84 %) |
Aug 13 2009 | ANPI | ANGIOTECH PHARMACE ... | Chen Jonathan W | SVP, Business Devel ... | Buy | P | 1.78 | 1,100 | 1,958 | 23,600 | 22.5 K to 23.6 K (+4.89 %) |
Aug 13 2009 | ANPI | ANGIOTECH PHARMACE ... | Chen Jonathan W | SVP, Business Devel ... | Buy | P | 1.77 | 2,900 | 5,133 | 22,500 | 19.6 K to 22.5 K (+14.80 %) |
Aug 13 2009 | ANPI | ANGIOTECH PHARMACE ... | Chen Jonathan W | SVP, Business Devel ... | Buy | P | 1.76 | 5,200 | 9,152 | 19,600 | 14.4 K to 19.6 K (+36.11 %) |
Aug 13 2009 | ANPI | ANGIOTECH PHARMACE ... | Chen Jonathan W | SVP, Business Devel ... | Buy | P | 1.78 | 1,900 | 3,382 | 14,400 | 12.5 K to 14.4 K (+15.20 %) |
Jun 25 2009 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | J | 17.41 | 60,000 | 1,044,600 | 655,000 | |
Jun 25 2009 | ANPI | ANGIOTECH PHARMACE ... | Avelar Rui | Chief Medical Offic ... | Option Exercise | J | 21.39 | 200,000 | 4,277,600 | 715,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal & Genera ... | Option Exercise | J | 17.41 | 60,000 | 1,044,600 | 625,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal & Genera ... | Option Exercise | J | 21.39 | 120,000 | 2,566,560 | 685,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | McMasters David | SVP, Legal & Genera ... | Option Exercise | J | 17.50 | 700,000 | 12,250,000 | 805,000 | |
Jun 25 2009 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | J | 18.00 | 60,000 | 1,080,000 | 700,000 | |
Jun 25 2009 | ANPI | ANGIOTECH PHARMACE ... | Bailey K Thomas | Chief Financial Off ... | Option Exercise | J | 17.41 | 50,000 | 870,500 | 760,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | J | 17.50 | 16,600 | 290,500 | 350,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Option Exercise | J | 17.41 | 8,400 | 146,244 | 366,600 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Option Exercise | J | 17.41 | 150,000 | 2,611,500 | 2,050,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Option Exercise | J | 21.39 | 400,000 | 8,555,200 | 2,200,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Option Exercise | J | 14.84 | 600,000 | 8,902,800 | 2,600,000 | |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Option Exercise | J | 15.63 | 300,000 | 4,687,500 | 3,200,000 | |
Jun 18 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.85 | 12,500 | 23,125 | 12,500 | 0 to 12.5 K |
Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research and D ... | Buy | P | 1.77 | 20,000 | 35,400 | 32,500 | 12.5 K to 32.5 K (+160.00 %) |
Jun 11 2009 | ANPI | ANGIOTECH PHARMACE ... | MCKINNELL HENRY A | Director | Option Exercise | A | 2.06 | 5,000 | 10,300 | 25,000 | |
Jun 11 2009 | ANPI | ANGIOTECH PHARMACE ... | Brown Edward M | Director | Option Exercise | A | 2.06 | 5,000 | 10,300 | 50,000 | |
Jun 11 2009 | ANPI | ANGIOTECH PHARMACE ... | Brege Laura | Director | Option Exercise | A | 2.06 | 5,000 | 10,300 | 30,000 | |
Jun 11 2009 | ANPI | ANGIOTECH PHARMACE ... | Willms Arthur H | Director | Option Exercise | A | 2.31 | 5,000 | 11,550 | 55,000 | |
Jun 11 2009 | ANPI | ANGIOTECH PHARMACE ... | HOWARD DAVID T | Director | Option Exercise | A | 2.31 | 5,000 | 11,550 | 160,000 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 0.21 | 5,000 | 1,050 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 0.21 | 5,000 | 1,050 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 3.96 | 5,000 | 19,800 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 7.73 | 5,000 | 38,650 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 10.01 | 5,000 | 50,050 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 14.86 | 5,000 | 74,300 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 17.11 | 5,000 | 85,550 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 16.10 | 5,000 | 80,500 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 21.93 | 5,000 | 109,650 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 27.75 | 5,000 | 138,750 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 13.47 | 30,000 | 403,950 | 0 | |
Jun 08 2009 | ANPI | ANGIOTECH PHARMACE ... | Richardson Hartley T | Director | Option Exercise | J | 13.47 | 30,000 | 403,950 | 0 | |
May 15 2009 | ANPI | ANGIOTECH PHARMACE ... | Neske Tammy | SVP, Human Resource ... | Buy | P | 1.35 | 5,500 | 7,425 | 5,500 | 0 to 5.5 K |
May 07 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Buy | P | 0.55 | 59,997 | 32,998 | 5,848,591 | 5.8 M to 5.8 M (+1.04 %) |
May 07 2009 | ANPI | ANGIOTECH PHARMACE ... | Hunter William L | President & CEO | Buy | P | 0.55 | 3,700 | 2,035 | 5,788,594 | 5.8 M to 5.8 M (+0.06 %) |